Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP166830.RAhbWZ7b5m5fDfpbY0zZZQZNWIkS-0oyOjlrH2TqjhyJc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP166830.RAhbWZ7b5m5fDfpbY0zZZQZNWIkS-0oyOjlrH2TqjhyJc130_assertion type Assertion NP166830.RAhbWZ7b5m5fDfpbY0zZZQZNWIkS-0oyOjlrH2TqjhyJc130_head.
- NP166830.RAhbWZ7b5m5fDfpbY0zZZQZNWIkS-0oyOjlrH2TqjhyJc130_assertion description "[In conclusion, slow acetylator status of NAT2 was a significant susceptibility risk factor for antituberculosis drug-induced hepatotoxicity; NAT2 genotyping may be a useful tool for predicting antituberculosis drug-induced hepatotoxicity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP166830.RAhbWZ7b5m5fDfpbY0zZZQZNWIkS-0oyOjlrH2TqjhyJc130_provenance.
- NP166830.RAhbWZ7b5m5fDfpbY0zZZQZNWIkS-0oyOjlrH2TqjhyJc130_assertion evidence source_evidence_literature NP166830.RAhbWZ7b5m5fDfpbY0zZZQZNWIkS-0oyOjlrH2TqjhyJc130_provenance.
- NP166830.RAhbWZ7b5m5fDfpbY0zZZQZNWIkS-0oyOjlrH2TqjhyJc130_assertion SIO_000772 17950035 NP166830.RAhbWZ7b5m5fDfpbY0zZZQZNWIkS-0oyOjlrH2TqjhyJc130_provenance.
- NP166830.RAhbWZ7b5m5fDfpbY0zZZQZNWIkS-0oyOjlrH2TqjhyJc130_assertion wasDerivedFrom befree-20140225 NP166830.RAhbWZ7b5m5fDfpbY0zZZQZNWIkS-0oyOjlrH2TqjhyJc130_provenance.
- NP166830.RAhbWZ7b5m5fDfpbY0zZZQZNWIkS-0oyOjlrH2TqjhyJc130_assertion wasGeneratedBy ECO_0000203 NP166830.RAhbWZ7b5m5fDfpbY0zZZQZNWIkS-0oyOjlrH2TqjhyJc130_provenance.